跳至主要内容
临床试验/NCT00488020
NCT00488020Unknown1 期

the Use of Autogenous Adult Stem Cells in the Treatment of Critical Ischemia

Instituto de Molestias Cardiovasculares2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2006年4月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
10
试验地点
2
主要终点
Suppress pain and heal ischemic ulcers

研究概览

简要总结

Collection of bone marrow blood Selection of mononuclear cells dilution with albumin injection into the calf muscles through 40 shots

详细描述

About 500cc of blood are collected from the iliac bone marrow under epidural anesthesia.In the cell therapy lab this blood is harvested and mononuclear cells are separated.This procedure takes roughly 4 hours.After dilution in albumin (40cc)the mononuclear cells are injected into the calf muscles through 40 shots.This procedure is indicated for patients with lower limb ischemia on whom all the others known therapies have failed

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Fontaine's classification grade 3 and 4 patients

排除标准

  • Record of cancer in the last 5 years
  • Over 80 years
  • Diabetic retinopathy

结局指标

主要结局

Suppress pain and heal ischemic ulcers

时间窗: 6 months

次要结局

  • improve quality of life(6 months)

研究者

发起方
Instituto de Molestias Cardiovasculares
申办方类型
Other

研究点 (2)

Loading locations...

相似试验